Physical symptoms and inflammatory levels characterize post-COVID-19 depressive episodes compared to
Maria Pepe1, Marco Di Nicola1, Giuseppe Mandracchia2
1Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Abstract:
Major depressive episodes (MDE) following COVID-19 have been described in approximately 30 % of cases. A clinical picture characterized by physical and cognitive symptoms with underlying immune-inflammatory changes has been reported. However, a comparison of post-COVID-19 MDE with non-post-COVID-19 depression is still lacking. This study aims to characterize 209 patients with MDE, post-COVID-19 vs. non-post-COVID-19, focusing on physical and cognitive symptomatology evaluated through Hamilton Depression (HDRS) and Anxiety Rating Scales (HARS), Digit Symbol Substitution Test (DSST), Perceived Deficits Questionnaire-Depression 5-items (PDQ-D5). Inflammatory levels were assessed with blood count-derived indexes. Post-COVID-19 group (46.9 % of patients) displayed higher rates of first-onset depressive episodes (p = 0.001), an older age at onset (p = 0.006), more physical and cognitive features according to subitems of HDRS (p = 0.001), HARS (p < 0.001), and PDQ-D5 scores (p = 0.019), as well as higher inflammatory indexes (p < 0.001). Logistic regression showed a significant association of post-COVID-19 MDE with physical symptomatology (p = 0.02) and Systemic Immune-Inflammatory Index (p = 0.04). Receiver Operating Characteristic (ROC) curves displayed a discriminative potential for this association (AUC = 0.921). These results highlight the specific clinical presentation of post-COVID-19 MDE, with prominent physical symptoms and increased inflammation levels, suggesting that a more careful characterization might inform personalized interventions and promote full functional recovery in these patients.
Insights
Major depressive episodes after COVID-19 often present with distinct physical and cognitive symptoms, alongside higher inflammation levels. This study differentiates these from non-COVID-19 depression, aiding targeted treatment strategies.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Major depressive episodes (MDE) affect approximately 30% of COVID-19 survivors.
- A specific clinical profile of post-COVID-19 MDE, including physical, cognitive, and immune-inflammatory changes, has been suggested.
- Direct comparisons between post-COVID-19 MDE and non-post-COVID-19 depression are limited.
Purpose of the Study:
- To characterize and compare the physical and cognitive symptomatology and inflammatory markers in patients with post-COVID-19 MDE versus non-post-COVID-19 depression.
- To identify specific features associated with MDE following COVID-19 infection.
Main Methods:
- A cohort of 209 patients with MDE was assessed, categorized into post-COVID-19 and non-post-COVID-19 groups.
- Symptomatology was evaluated using the Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), Digit Symbol Substitution Test (DSST), and Perceived Deficits Questionnaire-Depression 5-items (PDQ-D5).
- Inflammatory levels were measured using blood count-derived indexes, including the Systemic Immune-Inflammatory Index.
Main Results:
- The post-COVID-19 MDE group (46.9%) showed higher rates of first-onset depression, older age at onset, and more pronounced physical and cognitive symptoms (HDRS, HARS, PDQ-D5 scores).
- Elevated inflammatory indexes were significantly higher in the post-COVID-19 MDE group.
- Logistic regression identified a significant association between post-COVID-19 MDE and physical symptomatology and the Systemic Immune-Inflammatory Index, with high discriminative potential (AUC=0.921).
Conclusions:
- Post-COVID-19 MDE exhibits a distinct clinical presentation characterized by prominent physical symptoms and heightened systemic inflammation.
- These findings underscore the need for precise characterization of depression following COVID-19.
- Personalized interventions informed by specific clinical and inflammatory profiles may enhance functional recovery in affected patients.
More Related Videos
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Introduction to Stress and Lifestyle
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...


